Peterlin, Pierre, and Maxime Jullien. 2025. “Response to Comment On: FLT3 Ligand Kinetic Profile Predicts Response to Treatment in Patients With High-Risk Myelodysplastic syndrome/chronic Myelomonocytic Leukemia Receiving CPX-351: A Study from the Groupe Francophone Des Myélodysplasies”. Haematologica 110 (5). Pavia, Italy, 1237. https://doi.org/10.3324/haematol.2025.287378.